De Brauw Blackstone Westbroek advises across the full spectrum of life sciences mandates, from high-value patent litigation to investment and refinancing work. The practice is jointly headed by Anne Marie Verschuur, whose experience covers trade secrets and contested patent matters, and Gaby Smeenk, who acts on M&A and capital markets transactions. Bertrand ter Woort is a regular adviser to medical device and pharma clients, while Stephanie de Beer brings further expertise on patent validity and infringement disputes.
Legal 500 Editorial commentary
Accolades
Client satisfaction: Lawyer & team quality
Client satisfaction: Sector knowledge
Key clients
- Advanced Bionics(Sonova AG)
- Almirall B.V.
- AmyriAD Therapeutics
- Biogen
- Bristol Myers Squibb
- Byondis
- Corbion
- Duomed
- Eli Lilly
- Ferring
- Forbion
- G Square
- GSK
- Philips
- Koppert
- Pharmathen
- Qiagen
- Synthon
- Bergman Clinics
- Universitair Medisch Centrum Groningen
Work highlights
Represented Bristol-Myers Squibb in patent proceedings against Sandoz and Teva before the Dutch Supreme Court.
Advised the underwriters on the $479m public offering by NewAmsterdam Pharma Company N.V.
Representing Philips in a legal dispute against Boombrush, a Netherlands-based manufacturer of "The Brush" electronic toothbrush.
Practice head
Anne Marie Verschuur, Gaby Smeenk
Other key lawyers
Bertrand ter Woort; Tobias Cohen Jehoram; Stephanie de Beer
